LIST NEW US ETFS – etftrack.com http://etftrack.com Exchange Traded Funds (ETFs) Sun, 29 Mar 2020 19:24:45 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 UBIO, ZBIO: New +3x,-3x US Biotechnology ETFs by ProShares http://etftrack.com/ubio-zbio-new-3x-3x-us-biotechnology-etfs-by-proshares/ http://etftrack.com/ubio-zbio-new-3x-3x-us-biotechnology-etfs-by-proshares/#respond Mon, 22 Jun 2015 20:19:20 +0000 http://etftrack.com/?p=7192 ProShares begun trading 2 new ETFs: the UltraPro Nasdaq Biotechnology ETF (Nasdaq: UBIO) and the ProShares UltraProShort Nasdaq Biotechnology (Nasdaq: ZBIO) on Monday, June 22, 2015.
Here is a synopsis of the new ETFs:

1.
FUND INFORMATION: CLOSED 03/18/2020

Symbol: UBIO     Exchange: Nasdaq
Name: UltraPro Nasdaq Biotechnology ETF Net Expense Ratio: 0.95%

 

FUND OBJECTIVE:
The UltraPro Nasdaq Biotechnology ETF seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index.

 

2.
FUND INFORMATION: CLOSED 03/18/2020

Symbol: ZBIO  Exchange: Nasdaq
Name: UltraProShort Nasdaq Biotechnology Net Expense Ratio: 0.95%

 

FUND OBJECTIVE:
The UltraProShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the NASDAQ Biotechnology Index.

 

 

REFERENCE INDEX:
The NASDAQ Biotechnology Index is a modified capitalization-weighted index that includes securities of The NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The securities also meet other eligibility criteria determined by The NASDAQ OMX Group Inc., including minimum market capitalization and liquidity requirements.
As of May 31, 2015, the Index was comprised of 146 stocks and included companies with capitalizations between approximately $55.2 million and $165.0 billion. The average capitalization of the companies comprising the Index was approximately $7.0 billion.

 

Index Top 10 Holdings (03/31/15):

Biogen Idec Inc. 8.11%
Amgen Inc. 7.97%
Celgene Corp. 7.46%
Gilead Sciences Inc. 7.45%
Regeneron Pharmaceuticals Inc. 6.54%
Vertex Pharmaceuticals Inc. 3.88%
Alexion Pharmaceuticals Inc. 3.78%
Illumina Inc. 3.73%
Mylan N.V. 3.31%
BioMarin Pharmaceutical Inc. 2.95%

 

Index sectors Weights (03/31/15):

Consumer, Non-Cyclical 99.52%
Diversified 0.48%

 

Useful Links:

UBIO Home Page ZBIO Home Page

 

Category: Equities> Regions> USA> US Sectors/Industries> US Biotechnology

]]> http://etftrack.com/ubio-zbio-new-3x-3x-us-biotechnology-etfs-by-proshares/feed/ 0